Novogene is a genomic services and solutions
provider with cutting edge NGS and bioinformatics
expertise, and the largest sequencing capacities in...
the world. The company utilizes scientific expertise,
a commitment to customer service and unsurpassed
data See More
provider with cutting edge NGS and bioinformatics
expertise, and the largest sequencing capacities in...
the world. The company utilizes scientific expertise,
a commitment to customer service and unsurpassed
data See More
Location: China, Beijing, Chaoyang District
Employees: 1001-5000
Phone: +1 916-252-0068
Total raised: $75M
Founded date: 2011
Investors 1
| Date | Name | Website |
| - | SDIC Fund ... | sdicfund.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 30.11.2016 | Series B | $75M | - |
Mentions in press and media 11
| Date | Title | Description |
| 11.09.2025 | China’s Domestic Sequencers Take Bigger Market Share in First Half After Illumina Import Ban | (Yicai) Sept. 11 -- The Chinese market share of domestically made genome-sequencing products has increased in the first half of the year, as the country imposed an import ban on US gene-sequencing equipment giant Illumina early this year. A... |
| 23.06.2025 | Novogene Establishes New Subsidiary in Korea to Accelerate Multi-Omics Research | SEOUL, South Korea, June 23, 2025 /PRNewswire/ -- Novogene, a global leader in next-generation sequencing (NGS) and multi-omics solutions, today announced the establishment ofNovogene Korea Limited, a wholly owned subsidiary headquartered i... |
| 05.06.2025 | Novogene Certified for Olink® Services Across Multiple Labs; Expands Proteomics Portfolio with Olink® Reveal | SINGAPORE, June 5, 2025 /PRNewswire/ -- Novogene, a global leader in multi-omics solutions, is proud to announce its designation as an Olink® Certified Service Provider (CSP) across multiple laboratories worldwide. This milestone positions ... |
| 20.02.2025 | Chinese Rivals Seize on Illumina’s Blacklisting to Woo Clients | (Bloomberg) -- Beijing’s surprise move to blacklist Illumina Inc. has unleashed a frenzy among the US firm’s Chinese rivals to win market share from the gene-sequencing giant. While Illumina is still assessing the consequences of being adde... |
| 03.09.2024 | Next Generation Sequencing Market is poised to grow from USD 36.04 billion by 2031: Skyquest Technology | Share Tweet Share Share Email In recent years, next generation sequencing is a technique that employs massive parallelism in sequencing millions or even billions of DNA strands. This method is also known as high throughput sequencing. NGS i... |
| 07.05.2024 | NovogeneAIT Collaborates with A*STAR’s Institute of Molecular and Cell Biology on Spatial Transcriptomics Technology | SINGAPORE, May 7, 2024 /EINPresswire.com/ -- NovogeneAIT Genomics Singapore (“NovogeneAIT”) has entered into a research collaboration with A*STAR’s Institute of Molecular and Cell Biology (IMCB). This collaboration aims to elucidate the und... |
| 05.01.2023 | Novogene Announces Deployment of Illumina NovaSeq™ X Plus and PacBio REVIO Sequencing Systems | SINGAPORE, Jan. 5, 2023 /PRNewswire/ -- Novogene, a leading provider of genomic services and solutions, announced the addition of Illumina's latest high-throughput sequencing system NovaSeq™ X Plus and PacBio's Revio™ long-read sequencing s... |
| 02.10.2018 | Who am I? Young Chinese seek answer in genetic testing | |
| 01.12.2016 | China: Novogene Technology closes $75m Series B from CMB International, SDIC Unit | Premium Beijing-based Novogene Technology Co., Ltd., a commercial provider of genomic services and solutions with next-generation sequencing (NGS) and bioinformatics expertise, has completed a $75 Million (RMB515 Million) Series B round fin... |
| 01.12.2016 | Term Sheet — Thursday, December 1 | ET CETERA Dumb Pipes, Skinny Bundles and One Big Merger: Last night I stopped by Recode’s Code Media event in midtown Manhattan, where Turner CEO John Martin talked about the AT&T-Time Warner deal to a crowd of media execs. (Reminder: T... |
Show more